These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15107512)

  • 1. Efficacy and tolerability assessment of cefprozil in children with acute otitis media.
    Gupta N; Bagga V; Parmar BJ; Kar K; Mukherjee A; Mehta S; Moharana AK
    Indian J Pediatr; 2004 Apr; 71(4):319-24. PubMed ID: 15107512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
    Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR; Benfield P
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media.
    Hedrick JA; Sher LD; Schwartz RH; Pierce P
    Clin Ther; 2001 Feb; 23(2):193-204. PubMed ID: 11293553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media.
    Blumer JL; Forti WP; Summerhouse TL
    Clin Ther; 1996; 18(5):811-20. PubMed ID: 8930425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefprozil treatment of persistent and recurrent acute otitis media.
    Pichichero ME; McLinn S; Aronovitz G; Fiddes R; Blumer J; Nelson K; Dashefsky B
    Pediatr Infect Dis J; 1997 May; 16(5):471-8. PubMed ID: 9154539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
    Kafetzis DA
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):857-65. PubMed ID: 7889960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media.
    Block SL; Kratzer J; Nemeth MA; Tack KJ
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S147-52. PubMed ID: 11144396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-day versus ten-day treatment of acute otitis media with cefprozil.
    Kafetzis DA; Astra H; Mitropoulos L
    Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):283-6. PubMed ID: 9177961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.
    Nicolau DP; Sutherland CA; Arguedas A; Dagan R; Pichichero ME
    Paediatr Drugs; 2007; 9(2):119-23. PubMed ID: 17407367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
    Gehanno P; Berche P; Boucot I; Lambert-Zechovsky N; Bingen E; Gres JJ; Rollin C
    J Antimicrob Chemother; 1994 Jun; 33(6):1209-18. PubMed ID: 7928814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil.
    Aronovitz G
    Pediatr Infect Dis J; 1998 Aug; 17(8 Suppl):S83-8. PubMed ID: 9727656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric tonsillopharyngitis--an evaluation of cefprozil in Indian patients.
    Gupta N; Mukherjee A; Moharana AK
    Indian J Pediatr; 2004 Jul; 71(7):601-5. PubMed ID: 15280609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
    Barriere SL
    Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion.
    Arguedas AG; Zaleska M; Stutman HR; Blumer JL; Hains CS
    Pediatr Infect Dis J; 1991 May; 10(5):375-80. PubMed ID: 1906160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of therapeutic effectiveness of Cefprozil in a short 5-day course of empirical antibiotic therapy in ambulatory patients with bacterial infections of the upper respiratory tract and otitis media].
    Starostecka B
    Otolaryngol Pol; 2005; 59(1):147-8. PubMed ID: 15973798
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study.
    Quach C; Collet JP; LeLorier J
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):163-70. PubMed ID: 15386697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oral cephalosporins in the treatment of acute otitis media in children.
    Brook I
    Int J Antimicrob Agents; 2004 Jul; 24(1):18-23. PubMed ID: 15225855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
    McCarty JM; Pierce PF
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.